wordpress visitors
Wall Street E News Wall Street E News Wall Street E News
Wall Street E News
Wall Street E News
Wall Street E News Wall Street E News Wall Street E News - About Us Wall Street E News Wall Street E News - Featured Companies Wall Street E News Wall Street E News - Market News Wall Street E News Wall Street E News - Widgets Wall Street E News Wall Street E News - Join WSEN
Wall Street E News

Market Summary

DJIA 9908.39    -103.84
S&P500 1056.74    -9.45
NASDAQ 2126.05    -15.07
WSNA +150%

ADD .PK for Pinksheets
ADD .OB for OTC

Wall Street E News


Wall Street E News

Corporate Profile


image image
www.WallStreetENews.com - SUWN Trading Update


OTCBB: SUWN



Don’t miss your opportunity to profit from SUWN


LATEST NEWS RELEASE

Sunwin Receives Scientific and Technological Achievements Certificate for the Global Quality and Health Benefits of its Stevia Extracts

Shandong Province Office Affirms Quality at American, European Levels

Qufu, China, - Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), one of the top global providers of high quality Stevia extracts including Rebaudioside A 98, announced that it has received certification from the Shandong Province Science and Technology Office, the second largest GDP producing province in China. The certification recognizes Sunwin's Stevia extracts as meeting the standards established for high-grade extracts required in the American and European marketplaces. At the conclusion of these tests, the agency issued a Scientific and Technological Achievements Certification, a significant recognition in China.

Additionally, the provincial office certified the health and environmental benefits of Sunwin's Stevia extracts, including the production processes used to create all natural sweetening extracts and health benefits for weight loss and diabetic dietary requirements. Stevia is widely recognized as a replacement for sugar and high-calorie sweeteners, offering a low calorie diet option for those seeking to lose weight or control sugar intake as a complement to healthy diet and exercise regimens.

Sunwin continues to expand its environmentally-friendly practices beyond those inherent to the process of creating all natural sweetening extracts without the use of chemicals and synthetic materials.

"This recognition attests to the quality of Sunwin's Stevia products and gives the company preferred standing for future business growth with the support of the provincial government offices," said Dongdong Lin, CEO of Sunwin. "Our high-grade Stevia extracts offer food and beverage companies worldwide a reliable and competitive provider able to customize production for specific extract requirements. We are proud to be recognized by Shandong Province for our advancements in using Stevia as a natural sweetener in low calorie foods."

Shandong Province is China's largest agricultural producer and a top industrial and manufacturing region in China. The province has benefitted from significant business development efforts, including investment by Japanese and South Korean companies, which are also key export markets for Chinese stevia products. Shandong Province is home to approximately 92 million people.

Investors are urged to monitor the progress of the company!


Why Consider SUWN?

Strong Corporate Outlook

This company is on to something huge! With annual revenues in upwards of $20M, and a product that is poised to change the landscape of the Multi-Billion dollar Artificial Sweetener Market, SUWN has the right ingredients to sweeten any underperforming portfolio.

A few more reasons we think SUWN may be ready to take-off From the company's Financial Results (for its year-end 2009):
  • Now selling in 3000 US stores and online
  • OnlySweet™ addresses the expanding US stevia market, which is expected to reach more than $700 million.
  • Record Sales of Stevioside reaching $14.5 Million, up from $12.9 Million in Fiscal 2008
  • Revenue of $22 Million with Net Income of $500,000;
  • Total Cash of $10.49 Million, up 54% From Fiscal 2008;
  • Total Assets of $43.62 Million, up 45% from Fiscal 2008;
  • Shareholder Equity of $38.51 Million, up 45% from Fiscal 2008;
  • Continue profitable growth and improve net income
  • Recent accretive acquisitions expand vertical opportunities within the organic bio-fertilizer and animal feed industries
  • Growing global concern over obesity, health problems, and a preference for natural products is opening key markets to alternative sweetener choices, with Sunwin being one of the largest global suppliers.
  • Sunwin is deepening its vertical integration with selective acquisitions to enhance scale, capability, prod-uct range and profitability.
  • Plant expansion to enhance production can occur within 3-4 months of need identification.
  • Acceptance of Only Sweet. continues to grow in US retail and consumer packaged goods channels with additional retail stores and mass market chain adoption to come.
  • Sunwin USA is expanding the range of products using Only Sweet in retail food and beverage goods.
  • Sunwin will apply for FDA acceptance of Only Sweet as a sweetener product, expanding marketability of the product and food and beverage utilization opportunity.
  • The Company plans to continue growth of total revenue, gross profit and income while controlling costs through economies of scale.

    Increasing Product Demand

    Strong Corporate Growth Plan

  • Sunwin is expanding total global stevia manufacturing capacity and sales

  • Continue vertical integration opportunities in all markets

  • Expanding US presence by seeking both FDA clearance and entry to the wholesale food market

  • Growing global market opportunity for which Sunwin is one of the largest global mfrs.

    Diverse Revenue Streams

    STEVIOSIDE
    Stevioside is an all natural zero calorie sweetener and dietary supplement approximately 300 times sweeter than sugar. SUWN sells stevioside at the wholesale level to customers in China, Japan and South Korea. In 2006, SUWN expanded the distribution of stevioside into the US and Canadian markets. Production capacity is approximately 600 tons annually. This segment represented the majority of total net revenues for fiscal 2008 and 2007.

    VETERINARY MEDICINE
    Sunwin develops and produces medicines for the animal stock industry in the PRC, and develops special veterinary medicines made from pure traditional Chinese medicines or combining traditional Chinese medicine with Western medicine. Products in this group include veterinary medicine, animal feeds, feed additives and disinfectants sold throughout 28 provinces in China.

    TRADITIONAL CHINESE MEDICINE FORMULA EXTRACTS
    Sunwin manufactures and sells over 120 traditional Chinese medicine extracts on a wholesale basis to do-mestic traditional Chinese medicine manufacturers and large animal pharmaceutical manufacturers.

  • Company Snapshot

    About The Company

    Sunwin is engaged in the manufacture and sale of a wide range of neutraceutical products. Our product lines include zero-calorie all natural Stevia sweeteners, traditional Chinese medicines, as well as veterinary medicines and animal feeds prepared from 100% organic herbal ingredients. Sunwin has built an integrated global organization with the sourcing and production capabilities to satisfy the needs of global consumers.

    Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide quality, value, and a hybrid mix of agricultural products and services that meet the growing demand.


    Current Stock Data


    Recent Company News

    Disclaimer
    This advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company". The company also maintains a contractual, working relationship with Wall Street Capital Funding LLC. and its' Wall Street News Alert brand. For current services performed for China Direct Industries, Inc. ("China Direct Industries") (NasdaqGM: CDII), Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), Dragon Capital Group Corp (OTC: DRGV), China America Holdings (OTCBB: CAAH), China Armco Metals, Inc. (OTCBB: CNAM) and Dragon International Group Corp. (OTCBB: DRGG), the company has been compensated a total of Three Hundred Thousand Dollars (Two Hundred and Fifty Thousand dollars for current services and Fifty Thousand dollars for previous services) by China Direct Investments Inc., a Florida corporation, and a wholly owned subsidiary of China Direct. The company does not hold any shares of the stock. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

    The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.

    The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer. Investing in the public company that this release is providing service for should be reviewed as speculative and a high-risk and may result in the loss of some or all of any investment.

    This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.

    image image